• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Click here to download the  free ebook of Alberto Juantorena’s  detailed training workouts leading up to the 1976 Montreal Olympics

SpeedEndurance.com

Success in Track & Field ... and Life

  • Home
    • About
    • Contact
  • Track & Field
    • 400 meters
    • 800m & Mile
    • 1/2 & Full Marathons
    • Long & Triple Jump
    • Hurdles
  • Training
    • Weight Training
    • Abs & Core
    • Injury Prevention
    • Shoes & Spikes
    • Masters
  • Coaching
    • Freelap Friday Five
    • Interviews
    • Sports Nutrition
    • Sport Psychology
  • Archives
  • Shop
    • My account
    • Checkout
    • Basket

Winter Illness, Medication, and Athletic Enhancement Performance Training

You are here: Home / Coaching / Winter Illness, Medication, and Athletic Enhancement Performance Training
2
SHARES
FacebookTwitter

November 7, 2013 by Jimson Lee Leave a Comment

Cross posted on StrengthPowerSpeed.com.

Written by Robert A. Panariello MS, PT, ATC, CSCS, Professional Athletic Performance Center, New York.

As the winter season approaches, so does the emergence of various illnesses (i.e. upper and lower respiratory infections) and other conditions that are associated with both gram-negative and gram-positive bacteria. When faced with this type of ailment, the individual will usually seek the care of their physician who may elect to prescribe an antibiotic as the treatment of care. An increasingly popular prescribed remedy is the Fluoroquinolone class of antibiotics which includes the medications Ciprofloxacin (Cipro) and Levofloxacin (Levaquin). It appears the preference for these prescribed quinolones stems from their excellent gastrointestinal absorption, superior tissue penetration and broad spectrum activity.

There are many publications expressing concern with the soft tissue complications of increased risk of tendonitis and possible tendon rupture that may arise with the administration of these medications (i.e. Cipro, Levaquin). These concerns occur not only at the initiation of the patient’s treatment but up to several months after the conclusion of the prescribed treatment. These complications may affect tendons in various parts of the body (i.e. shoulder, knee, and ankle) with the Achilles tendon being the anatomical structure most affected. The risk also appears to be higher with those individuals whom are concomitantly taking corticosteroid drugs and in older individuals, especially those over 60 years of age.

It has been suggested that the fluoroquinolone antibiotics alter tendon fibroblast metabolism. In a study performed at the Laboratory for Soft Tissue Research at the Hospital for Special Surgery in New York, the administration of Cipro resulted in a 66% to 68% decrease in cell proliferation in the Achilles tendon, paratenon and shoulder capsule anatomy as well as a 36% to 48% decrease in collagen synthesis when compared to control cells. This particular study concluded that the inhibition of both cell proliferation and synthesis of matrix ground substance may contribute to the clinically described tendinopathies associated with ciprofloxacin therapy.

See also  Steroid Doesn't Help. In Fact, It Is Detrimental To Sprints

At the time of illness some “die hard” training individuals may continue to lift heavy weights and train before resolving their medical condition as they are of the opinion that they are protected while taking these medications during training. Other individuals may wait until their illness is resolved prior to returning to the gym to resume their training. Regardless of when the individual resumes their physical training, there is documented concern when taking this class of antibiotic medication.

I personally have treated a number of athletes who had ruptured their Achilles tendon at the time they were treated with Cipro or Levaquin. I am also familiar with one of my professional peers, whom shortly after completing his prescribed treatment with Cipro ruptured his pectoralis major bench pressing as he was warming up with 185 pounds.

Although tendon ruptures and pathology due to the use of the Fluoroquinolone class of medications may be rare, incidences of these types of cases are well documented in the literature. When evaluated for your illness, inform your physician, the medical expert, of your training background so that an appropriate medication may be prescribed for a positive outcome.

When training a client and/or athlete who is initially prescribed or has just completed a course of medication, it would be wise to inquire about the type of medication prescribed. I am not asserting that a client and/or athlete will definitively acquire tendon pathology nor disrupt an anatomical structure when placed on fluoroquinolone antibiotics. However when confronted with the possible training of individuals who were prescribed these type of medications the professional should be aware of the possible risks that may occur in the weight room or during other aggressive methods of training. If your clients and/or athletes are prescribed a Fluoroquinolone class of medication, place special attention to their training intensities and program design. As the old saying states, an ounce of prevention is worth a pound of cure.

See also  Linford Christie Advanced Plyometric Training

References

1. Almekinders LC, and Deol G, The Effects of Aging, Antiiflamatory Drugs, and Ultrasound on the In Vitro Response of Tendon Tissue, Am J Sports Med, July 1999 27 412- 421
2. Halpern AA, Horowicz BG, and Nagel DA, Tendon Ruptures Associated with Corticosteroid Therapy, West J Med 1977 November 127(5): 378 – 382
3. Kim GK, The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture, J Clin Aesthet Dermatol, 2010 April;3(4): 49 – 54
4. Williams RJ, Wickiewicz TL, and Hannafin JA, The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism, Am J Sports Med 2000, May – June;28(3):364 – 369

Category iconCoaching,  Health & Wellness,  Success,  Training

About Jimson Lee

I am a Masters Athlete and Coach currently based in London UK. My other projects include the Bud Winter Foundation, writer for the IAAF New Studies in Athletics Journal (NSA) and a member of the Track & Field Writers of America.

Reader Interactions

Leave a Reply Cancel reply

Primary Sidebar

Recommended

https://www.youtube.com/watch?v=0xbs-aWxyLk

Shop Our Store

  • Bud Winter (9)
  • Championship Productions (6)
  • Clyde Hart (2)
  • Derek Hansen (1)
  • Electrical Muscle Stimulation (2)
  • Jim Hiserman (6)
  • Jimson Lee (4)
  • Uncategorised (0)

Articles by Category

Products

  • Jim Hiserman - Developing 800m Runners: Identifying, Categorizing and Developing 400m-800m Type Athletes $42.99 $39.99
  • Private Coaching - Monthly Plan $600.00 $525.00
  • Jim Hiserman-Developing-Distance-Runnersv2 Jim Hiserman - Developing Distance Runners Volume 2: A Systematic Approach to Developing Individual Success within a Dynamic Team Culture $34.95 $29.95
  • Feed-the-Cats-Clinic-3-Pack-701 'Feed the Cats' Clinic 3-Pack $64.99
  • Tony Holler's Feed the Cats": A Complete Sprint Training Program Tony Holler's "Feed the Cats" Complete Sprint Training Program $49.99
  • Bud Winter and Speed City presents Arthur Lydiard 509x716 Bud Winter & Arthur Lydiard MP3 [Download only] $9.99

RECENT POSTS

  • Oregon22 Coaches Club now Online
  • IFAC 2022: The Return of In-Person Conferences (with Virtual option)
  • Here is our 400m Discussion Recording… over 2 Hours Long
  • The Best Free Coaching Book – post Beijing 2022 Olympics
  • The Ultimate 400m Track Webinar for Coaches & Athletes
  • NACAC Athletics Coaching Science Series 2022
  • Top Six 400m Predictor Workouts (Number 4 is my Favourite)
  • Best 6 Podcasts for 2021 (and Beyond)
  • Why Karsten Warholm’s 45.94 400mH WR is my Highlight of 2021
  • Sprinting: 10 Research Articles for Effective Sprint Training [Part 23]

Copyright © 2023. SpeedEndurance.com is owned and operated by Aryta Ltd. Privacy Policy | Cookie Policy
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}